These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10541383

  • 1. Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest.
    Juweid ME, Blumenthal RD, Lew W, Hajjar G, Rubin AD, Goldenberg DM.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3337s-3342s. PubMed ID: 10541383
    [Abstract] [Full Text] [Related]

  • 2. Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression.
    Blumenthal RD, Alisauskas R, Lew W, Sharkey RM, Goldenberg DM.
    Exp Hematol; 1998 Aug; 26(9):859-68. PubMed ID: 9694507
    [Abstract] [Full Text] [Related]

  • 3. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 4. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou SY, Zhou AP, Zhang CG, Ai B.
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 6. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
    Shi Y, Han X, He X, Yang J, Liu P.
    Zhonghua Yi Xue Za Zhi; 2002 Apr 10; 82(7):462-6. PubMed ID: 12133516
    [Abstract] [Full Text] [Related]

  • 7. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov 10; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions.
    Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5916s-5920s. PubMed ID: 7493370
    [Abstract] [Full Text] [Related]

  • 9. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.
    Bone Marrow Transplant; 2006 Apr 01; 37(7):661-8. PubMed ID: 16489358
    [Abstract] [Full Text] [Related]

  • 10. Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies.
    Juweid ME, Zhang CH, Blumenthal RD, Hajjar G, Sharkey RM, Goldenberg DM.
    J Nucl Med; 1999 Oct 01; 40(10):1609-16. PubMed ID: 10520699
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R, Robinson S, Sheridan T, Mauch PM.
    Stem Cells; 2000 Oct 01; 18(2):120-7. PubMed ID: 10742384
    [Abstract] [Full Text] [Related]

  • 12. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May 01; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 13. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
    Juweid ME, Hajjar G, Stein R, Sharkey RM, Herskovic T, Swayne LC, Suleiman S, Pereira M, Rubin AD, Goldenberg DM.
    J Nucl Med; 2000 Jan 01; 41(1):93-103. PubMed ID: 10647610
    [Abstract] [Full Text] [Related]

  • 14. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.
    Eur J Haematol; 2007 Feb 01; 78(2):111-6. PubMed ID: 17313558
    [Abstract] [Full Text] [Related]

  • 15. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK, Kim JG, Seo KW, Chae YS, Jung JT, Suh JS, Lee KB.
    Bone Marrow Transplant; 2002 Jul 01; 30(2):81-6. PubMed ID: 12132046
    [Abstract] [Full Text] [Related]

  • 16. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X, Shao Y, Ren B, Tong Z, Ren X, Li L, Zhang Z, Zhang N, Dai R, Hao X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 May 01; 21(5):247-9. PubMed ID: 11876989
    [Abstract] [Full Text] [Related]

  • 17. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY, Qiu LG, Li QC, Meng HX, Wang YF, Yu Z, Li Q, Han JL.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 14; 86(42):2966-70. PubMed ID: 17288807
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C, Urbano-Ispizua A, Marín P, Merino A, Rovira M, Carreras E, Montserrat E.
    Bone Marrow Transplant; 1999 Dec 14; 24(12):1273-8. PubMed ID: 10627634
    [Abstract] [Full Text] [Related]

  • 19. Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.
    Colnot DR, Ossenkoppele GJ, Roos JC, Quak JJ, de Bree R, Börjesson PK, Huijgens PC, Snow GB, van Dongen GA.
    Clin Cancer Res; 2002 Nov 14; 8(11):3401-6. PubMed ID: 12429627
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, Abe T, Kawano Y, Kagami S, Takaue Y.
    Vox Sang; 2005 Nov 14; 89(4):229-35. PubMed ID: 16262756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.